AR019664A1 - COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES - Google Patents
COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASESInfo
- Publication number
- AR019664A1 AR019664A1 ARP990102842A AR019664A1 AR 019664 A1 AR019664 A1 AR 019664A1 AR P990102842 A ARP990102842 A AR P990102842A AR 019664 A1 AR019664 A1 AR 019664A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- cartilago
- diseases
- composition
- optionally substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Abstract
Una composicion farmacéutica para la prevencion y/o tratamiento de una enfermedad del cartílago, que comprende un compuesto (I) de formula(1) en donde elanillo A es un anillo bencénico opcionalmente sustituido; R es un átomo de hidrogeno o un grupo hidrocarbonado opcionalmente sustituido; B es un grupocarboxilo opcionalmente esterificado o convertido en amida; X es -CH(OH)- o -CO-; k es 0 o 1; y k es 0, 1 o 2, o su sal y método para su uso.A pharmaceutical composition for the prevention and / or treatment of a cartilage disease, comprising a compound (I) of formula (1) in which Elanillo A is an optionally substituted benzene ring; R is a hydrogen atom or an optionally substituted hydrocarbon group; B is an optionally esterified or converted to amidecarboxyl group; X is -CH (OH) - or -CO-; k is 0 or 1; and k is 0, 1 or 2, or its salt and method of use.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16750798 | 1998-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR019664A1 true AR019664A1 (en) | 2002-03-13 |
Family
ID=15850970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990102842 AR019664A1 (en) | 1998-06-15 | 1999-06-15 | COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1087774A2 (en) |
AR (1) | AR019664A1 (en) |
AU (1) | AU4165699A (en) |
CA (1) | CA2334815A1 (en) |
WO (1) | WO1999065474A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5194999A (en) | 1998-08-07 | 2000-02-28 | Takeda Chemical Industries Ltd. | Benzothiepin derivatives, process for the preparation of the same and uses thereof |
US20030187054A1 (en) * | 2000-03-10 | 2003-10-02 | Shunsuke Nagao | Preparations for chondrogenesis |
WO2001089521A1 (en) * | 2000-05-23 | 2001-11-29 | Takeda Chemical Industries, Ltd. | Medicinal compositions containing thiophene derivatives |
FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | Hica for use in prophylaxis and/or treatment of a disease or condition involving degradation of cartilage and/or disruption of cartilage homeostasis and/or integrity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK656789A (en) * | 1988-12-28 | 1990-06-29 | Takeda Chemical Industries Ltd | BENZOHETEROCYCLIC COMPOUNDS |
ATE203020T1 (en) * | 1990-05-30 | 2001-07-15 | Takeda Chemical Industries Ltd | SULFUR CONTAINING HETEROCYCLIC COMPOUNDS |
TW403757B (en) * | 1994-12-28 | 2000-09-01 | Takeda Chemical Industries Ltd | Optically active benzothiepin derivative, its preparation and use |
CA2221784A1 (en) * | 1995-06-05 | 1996-12-12 | Takeda Chemical Industries, Ltd. | Osteogenetic promoting pharmaceutical composition |
EP0949927B1 (en) * | 1996-08-26 | 2002-10-16 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
-
1999
- 1999-06-14 EP EP99925310A patent/EP1087774A2/en not_active Withdrawn
- 1999-06-14 WO PCT/JP1999/003154 patent/WO1999065474A2/en not_active Application Discontinuation
- 1999-06-14 CA CA002334815A patent/CA2334815A1/en not_active Abandoned
- 1999-06-14 AU AU41656/99A patent/AU4165699A/en not_active Abandoned
- 1999-06-15 AR ARP990102842 patent/AR019664A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1999065474A3 (en) | 2000-04-06 |
AU4165699A (en) | 2000-01-05 |
WO1999065474A2 (en) | 1999-12-23 |
EP1087774A2 (en) | 2001-04-04 |
CA2334815A1 (en) | 1999-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193142T3 (en) | USE OF BENZOTIOPHENES FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA. | |
BR9611015A (en) | Compound, pharmaceutical composition and process for the treatment of an inflammatory disease susceptible to treatment with a non-toxic non-steroidal anti-inflammatory agent, pharmaceutically acceptable salt, use of a compound | |
ES2124612T3 (en) | DIHYDRODIBENZE (B, F) AZEPINS, SUBSTITUTED, METHOD FOR THE PREPARATION, THEIR USE IN THE TREATMENT OF VARIOUS CENTRAL NERVOUS SYSTEM DISORDERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
BR0108600A (en) | Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and methods for treating a chemokine-mediated disease and for treating an inflammatory disease | |
BR0010555A (en) | Neuraminidase Inhibitors | |
UY26199A1 (en) | NEW BENZENE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
BR9406979A (en) | Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound | |
BR0113776A (en) | Composition of selected fused pyrrolocarbazoles and method for treating and preventing various diseases using said composition | |
BRPI0111116B8 (en) | thrombopoietin mimics | |
YU56995A (en) | ONLY DERIVED INDOLA | |
BR0010119A (en) | Composition to prevent or treat dementia containing a hydroxycinnamic acid derivative or an extract from a genus angelicae plant containing the same | |
RU93005334A (en) | DERIVATIVES OF STEROIDS FOR THE TREATMENT OF HYPERTROPHY OF THE PROSTATE GLAND, METHOD FOR PRODUCING THEM, USE, PHARMACEUTICAL COMPOSITION | |
ES2155566T3 (en) | USE OF RIFAMYCIN DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES BY CLAMIDIA. | |
AR019496A1 (en) | AZALIDAS OF 13 MEMBERS, PHARMACEUTICAL COMPOSITIONS, USE IN THE PREPARATION OF MEDICINES AND PREPARATION OF THE SAME | |
ES2055035T3 (en) | A PROCESS FOR THE PREPARATION OF AN ANTHRACICLINE GLYCOSIDE. | |
CO4820432A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS INCLUDING ACID 2- (4- (DIFENILMETIL) -1-PIPERACINIL) -ACE- TICO OR DERIVED AMIDE AND A SELECTED COMPOUND OF PSEUDOE FEDRINE, PHENYLPROPANOLAMINE AND PHENYLEPHRINE | |
ES2156120T3 (en) | ARILAMIDIC DERIVATIVES. | |
BR9507231A (en) | Use of carboxylic acid derivatives for drug production | |
KR970074763A (en) | Fluorinated Vitamin D₃ Analogs | |
IS1664B (en) | New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect | |
AR003137A1 (en) | A PHARMACEUTICAL COMPOSITION TO TREAT LEUKEMIA | |
ES2181927T3 (en) | DERIVATIVES OF 1-METILCARBAPENEM. | |
ATE181333T1 (en) | AZIRDINE DERIVATIVES, THEIR PREPARATION AND USE | |
AR012124A1 (en) | A PROCEDURE FOR THE PREPARATION OF TIAZOLIDINADIONA DERIVATIVES, TIAZOLIDINADIONA DERIVATIVES, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES. | |
AR019664A1 (en) | COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES |